Recombinant Human CGAS Protein，His

CGAS (cyclic GMP-AMP synthase) is a crucial enzyme in the innate immune response, playing a significant role in recognizing cytosolic DNA and initiating a signaling cascade that leads to the production of type I interferons. This process is essential for the detection of infections and cellular stress, as well as for maintaining genomic integrity. CGAS is activated upon binding to double-stranded DNA, leading to the synthesis of cyclic GMP-AMP (cGAMP), which acts as a second messenger to activate the STING (stimulator of interferon genes) pathway. Research has shown that dysregulation of CGAS can contribute to various autoimmune diseases and cancer, highlighting its potential as a therapeutic target. The study of recombinant CGAS proteins is critical for understanding its structure-function relationships, elucidating activation mechanisms, and facilitating the development of CGAS-targeted therapies. By producing and characterizing recombinant CGAS, researchers can explore its enzymatic activity, identify regulatory domains, and assess how mutations might affect its function. This research is pivotal for designing novel immunomodulatory drugs and for providing insights into the role of CGAS in health and disease, ultimately paving the way for advanced therapeutic strategies against infections and autoimmune disorders.